Superbug Solutions News Today

A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics

A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics.

The bacteria also showed no signs of developing resistance to the shape-shifting antibiotics.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Naarden, The Netherlands – 20 July 2022 – Forbion, a leading European life sciences venture capital firm, today announces the appointments of Dr. Peter Høngaard Andersen and Dr. Matt Cooper as Operating Partner and Venture Partner, respectively, expanding the Forbion team, network and expertise in...

The syringe was "very full, very large," and it would make sitting down uncomfortable for a while. "Kit" had gone to the health center in Chicago for a full panel of STI tests — it had been a minute, after all, and regular screenings are an important part of safe, multi-partner relationships. During the test, they were told the health center would be double-checking for gonorrhea — "theres a new antibiotic-resistant strain" about, Kit explains. Kit tested positive for the bacteria. Fear...

CARB-X to fund development of drug to rejuvenate ineffective antibiotics CARB-X announced today that it is awarding up to $2.2 million to the University of Queenslands Institute for Molecular Bioscience (IMB) to continue developing new compounds designed to boost antibiotics that have become ineffective against drug-resistant bacterial infections. The award will help fund IMBs octapeptins research program, which is developing octapeptin peptides that can disrupt the protective outer cell membra...

Share Holding off the rise of superbugs could be achieved by ‘resuscitating’ old antibiotics, with The University of Queensland researchers leading an international project to help combat the growing threat. CARB-X, a global non-profit partnership funding the world’s largest antibacterial development pipeline, has funded the $AU2.9m project at UQ’s Institute for Molecular Bioscience (IMB). Associate Professor Mark Blaskovich, Dr Alysha Elliott and Dr Johannes Zuegg will assess w...

Cannabidiol analogs active against wide range of Gram-positive bacteria and a subset of Gram-negative bacteria, including those responsible for gonorrhea, meningitis, and Legionnaires’ disease

The main nonpsychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, which could lead to the first new class of antibiotics for resistant bacteria in 60 years.